- Home
- QNCX vs AUID Comparison
QNCX vs AUID Comparison
Compare QNCX & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | AUID |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 18.4M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | QNCX | AUID |
|---|---|---|
| Price | $18.63 | $0.88 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 168.7K | ★ 236.6K |
| Earning Date | 04-10-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | ★ 2.88 | N/A |
| Revenue | N/A | ★ $2,040,660.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.53 | ★ N/A |
| Revenue Growth | N/A | ★ 130.20 |
| 52 Week Low | $0.08 | $0.76 |
| 52 Week High | $20.72 | $4.70 |
Technical Indicators
Market Signals| Indicator | QNCX | AUID |
|---|---|---|
| Relative Strength Index (RSI) | 83.38 | 34.40 |
| Support Level | $0.68 | N/A |
| Resistance Level | $19.26 | $1.39 |
| Average True Range (ATR) | 1.46 | 0.13 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 65.57 | 22.70 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.